Cartesian Therapeutics (RNAC) Tops Q2 EPS by 134c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: RNAC) | Delayed: 6.42 +0.02 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.40 | 52 Week High | $ | |||
| Open | $6.42 | 52 Week Low | $ | |||
| Day High | $6.71 | P/E | N/A | |||
| Day Low | $6.40 | EPS | $ | |||
| Volume | 105,973 | |||||
